-
A federal appeals court upheld the constitutionality of the state’s first-in-the-nation law that restricts drug company access to some information about doctors’ prescription-writing habits.
-
A vaccine aimed at preventing cervical cancer in women can prevent genital warts in men, according to a study released Thursday by the vaccine’s maker.
-
Not every older person can undergo open-heart surgery, but the results seen in two new studies show that doctors have become good at figuring out who can.
-
Aspirin medicines from Bayer intended to promote healthy hearts are being illegally marketed with unproven health claims, federal regulators said.
-
Smoking will be permitted again in the city’s 11 casinos for at least the next year, as the City Council voted to overturn a temporary smoking ban.
-
Food allergies now affect about 3 million American children, according to the first federal study of the problem.
-
Adult smokers should be vaccinated against infections caused by common respiratory bacteria, according to a scientific committee at the federal Centers for Disease Control and Prevention.
-
To meet the new recommendation of 400 units daily, millions of children will need to take vitamin D supplements each day.
-
An advocacy group is suing over an Oklahoma law that prohibits a woman from having an abortion unless she first has an ultrasound and the doctor describes to her what the fetus looks like.
-
A federal appeals court and the Ohio Supreme Court have rejected arguments that a death row inmate is too obese to die by lethal injection.
-
The figures represent the government’s first substantial study of vaccination rates for Gardasil, a vaccine against a virus responsible for about 70 percent of cervical cancers.
-
Immunization could lower rates of cervical cancer, according to experts, but many parents remain skeptical.
-
The pharmaceutical company said that it was shifting its research focus to diseases that have high potential for treatment improvements, like cancer and Alzheimer’s disease.
-
A federal study of an X-ray alternative to the dreaded colonoscopy confirms its effectiveness at spotting most cancers, although it was far from perfect.
-
A federal study of an X-ray alternative to colonoscopies confirms its effectiveness at spotting most cancers.
-
The government blocked the importation of more than 30 generic drugs made by India’s biggest pharmaceutical company, citing poor quality in two of its factories.
-
Federal regulators defended their assessment that bisphenol A is safe even as a preliminary study reported increased health risks.
-
Federal officials ordered stronger warnings on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the risk of possibly fatal fungal infections.
-
A radioactive tracer that “lights up” cancer hiding inside dense breasts showed promise in its first big test against mammograms.
-
Government toxicologists have reiterated safety concerns about bisphenol A, just weeks after the Food and Drug Administration declared the substance safe.
-
The rate of teen suicide remains disturbingly high, researchers said, possibly fueled by drug warnings that have scared many from using antidepressants.
-
The Food and Drug Administration approved Nplate for patients with a disorder that causes the body to attack its own platelets, tiny components of blood that help with clotting.
-
A federal judge has ordered a research company to supply an experimental drug to a 16-year-old Minnesota boy who is terminally ill with muscular dystrophy.
-
A family says a drug company led them to believe that their 16-year-old son could participate in a clinical trial for an experimental muscular dystrophy drug, but then went back on its word.
-
Federal regulators are working on a stronger label for a widely used diabetes drug, Byetta, after deaths continue to be reported despite earlier government warnings.
-
Despite safety concerns from parents, consumer groups and politicians, a chemical used in baby bottles and canned food is not dangerous, according to the F.D.A.
-
Three heart transplants involving babies have provoked an ethical debate over the circumstances under which organs should be removed.
-
For couples with unexplained infertility, artificial insemination and a drug stimulating ovulation are no better than simple counseling, scientists said.
-
Biogen Idec Inc. and Elan Corporation defended Tysabri on Friday, saying the treatment is still worth the risk to patients.
-
Shares of Biogen Idec and Elan Corporation plunged in after-hours trading after the companies reported two cases of a rare brain disease in patients treated with their multiple sclerosis drug Tysabri.
-
A company that hired a pregnant teenager who died of heat stroke this spring after laboring in a Central Valley vineyard received the highest fine ever issued to a California farming operation.
-
On a day when the major stock indexes were down significantly, the drug makers’ shares got little traction despite their fairly strong reports.
-
The UnitedHealth Group beat Wall Street expectations on Tuesday, and its shares rose despite a sharp drop in second-quarter profit.
-
Dr. DeBakey, a world-famous cardiovascular surgeon, pioneered such now-common procedures as bypass surgery and invented devices to help heart patients.
-
The American Medical Association formally apologized on Thursday for more than a century of policies that excluded blacks from the group, long considered to be the voice of American doctors.
-
The German health care company Fresenius said it had agreed to buy the American generic drug maker APP Pharmaceuticals for $3.7 billion.
-
Diabetes drugs would be subject to more stringent safety standards under recommendations made Wednesday by a government panel.
-
The government is about to start testing numerous other types of fresh produce in the hunt for the source of the nation’s record salmonella outbreak.
-
A federal advisory panel has endorsed two new vaccines designed to reduce the number of needle sticks that young children must endure to get the recommended immunizations.
-
Food and Drug Administration inspectors headed for farms in Florida and Mexico as new clues emerged to the possible source of salmonella-tainted tomatoes that have now sickened 552 people.
-
An experimental treatment that boosted a 52-year-old patient’s immune system to fight advanced skin cancer was successful, his doctors report.
-
The Food and Drug Administration warned doctors that prescribing a group of antipsychotic drugs to older people suffering from dementia could increase their risk of death.
-
Bolstering the performance of the health care system is one of the biggest challenges facing the country, the Federal Reserve chairman said Monday.
-
Bolstering the performance of the health care system is one of the biggest challenges facing the country, the Federal Reserve chairman said Monday.
-
The average American is living past age 78, though life spans are still shorter than in other developed countries, according to new data from the federal Centers for Disease Control and Prevention.
-
The average American is living past age 78, though lifespans are still shorter than in other developed countries, according to new data from the federal Centers for Disease Control.
-
Raw tomatoes have sickened people in 17 states and federal officials are seeking the source of contamination.
-
Raw tomatoes may have sickened scores of people in nine states, the Centers for Disease Control and Prevention announced Tuesday.
-
Gov. Charlie Crist has signed a bill requiring the state’s elementary schools to provide 30 minutes of continuous exercise daily for their students.
-
Patients in the earliest stages of the disease are lobbying for more research and increased resources.
-
The movie “Lorenzo’s Oil” told the story of Mr. Odone’s parents’ battle to save him from a nerve disease.
-
Nearly 40,000 military personnel have been given diagnoses of post-traumatic stress disorder since 2003, Pentagon records show.
-
The Coxsackievirus caused two deaths in California and one each in Illinois, Colorado and New Mexico, health officials said.
-
The drug maker has agreed to pay $58 million as part of a multistate settlement concerning advertising for the now-withdrawn painkiller.
-
Breast cancer patients with low levels of vitamin D were much more likely to die of the disease than patients getting enough of the nutrient, a study found.
-
Experts say the anti-bleeding drug, now off the market, likely will never return.
-
The one-time vaccination can prevent painful rashes, scarring and nerve damage, said federal officials.
-
New research shows exercise during the teen years — starting as young as age 12 — can help protect girls from breast cancer when they’re grown.
-
For the first time, more than half of insured adults regularly rely on prescription drugs, according to new data.
-
Eli Lilly and Co. broke ranks with the industry and endorsed a bill that would require prescription drug makers to disclose payments to doctors.
-
New research shows exercise in the teenage years, starting as young as age 12, can help protect girls from breast cancer when they are grown.
-
More than 80 patients may have contracted hepatitis C from two outpatient facilities, officials said.
-
Public Citizen, a consumer advocacy group, petitioned the government to pull the birth control patch off the market, calling it far riskier than the pill.
-
A consumer advocacy group petitioned the government Thursday to pull the birth-control patch off the market, calling it far riskier than the pill.
-
Getting too little sleep, or too much, is linked to poor health in a new federal study.
-
Wal-Mart announced it would expand its discounted prescription drug program to offer 90-day supplies for $10 and add several women’s medications at a discount.
-
More than 70 employees at state mental hospitals in Texas have been fired since 2005 over accusations of brutal beatings and other physical abuse, according to a newspaper report on Sunday.
-
The drug developer Bristol-Myers Squibb said it would sell ConvaTec, its wound therapy and surgical care unit, for $4.1 billion to two private equity firms.
-
Inspectors said the West Point, Pa., plant, which recalled two vaccines in December over sterility problems, had determined that manufacturing rules were not being followed.
-
An experimental cholesterol drug being developed by Merck & Company was rejected by the Food and Drug Administration, the company said on Monday.
-
The F.D.A. is taking a new look at whether warnings about the risks of Lasik surgery are appropriate.
-
The F.D.A. is taking a new look at whether warnings about the risks of Lasik surgery are appropriate.
-
The 95-0 Senate vote sends the Genetic Information Nondiscrimination Act back to the House, which could approve it early next week.
-
The Food and Drug Administration was criticized for not doing more checks of foreign drug manufacturers in the wake of problems with the blood thinner heparin and other products.
-
The Food and Drug Administration was criticized for not doing more checks of foreign drug manufacturers in the wake of problems with the blood thinner heparin and other products.
-
The Food and Drug Administration was criticized for not doing more checks of foreign drug manufacturers in the wake of problems with the blood thinner heparin and other products.
-
Mortality due to air pollution should be taken into account when measuring the benefits of proposed clean-air legislation, according to a new report.
-
The Food and Drug Administration was criticized for not doing more checks of foreign drug manufacturers in the wake of important problems with the blood thinner heparin and other products.
-
New York City health officials won a victory Wednesday when a federal judge upheld a regulation requiring some chain restaurants to post calories on menus.
-
New York City health officials won a victory Wednesday when a federal judge upheld a regulation requiring some chain restaurants to post calories on menus.
-
Shares in the drugmaker soared on news that it reached a deal with an Indian company, delaying the release of a generic competitor to its heartburn drug Nexium.
-
Shares in the drugmaker soared on news that it reached a deal with an Indian company, delaying the release of a generic competitor to its heartburn drug Nexium.
-
Shares in the drugmaker soared on news that it reached a deal with an Indian company, delaying the release of a generic competitor to its heartburn drug Nexium.
-
Shares in the drugmaker soared on news that it reached a deal with an Indian company, delaying the release of a generic competitor to its heartburn drug Nexium.
-
Millions of baby boomers are about to enter a health care system for seniors that not only isn't ready for them, but may even discourage them from getting quality care.
-
Amid new controversy about vaccines and autism, the government will give vaccine critics a say in shaping how the nation researches immunization safety questions.
-
Amid new controversy about vaccines and autism, the government will give vaccine critics a say in shaping how the nation researches immunization safety questions.
-
House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical specialists to discuss Vytorin, after lawmakers began investigating a failed study of the drug.
-
House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical specialists to discuss Vytorin, after lawmakers began investigating a failed study of the drug.
-
House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical specialists to discuss Vytorin, after lawmakers began investigating a failed study of the drug.
-
House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical specialists to discuss Vytorin, after lawmakers began investigating a failed study of the drug.
-
House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical specialists to discuss Vytorin, after lawmakers began investigating a failed study of the drug.
-
House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical specialists to discuss Vytorin, after lawmakers began investigating a failed study of the drug.
-
House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical specialists to discuss Vytorin, after lawmakers began investigating a failed study of the drug.
-
House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical specialists to discuss Vytorin, after lawmakers began investigating a failed study of the drug.
-
Surgeons at Johns Hopkins in Baltimore transplanted a half-dozen kidneys simultaneously, an operation believed to be the first of its kind, hospital officials announced.
-
The State Senate voted 21 to 15 to approve a bill that would offer such employees up to six weeks’ paid leave.
-
The State Senate voted 21 to 15 to approve a bill that would offer such employees up to six weeks’ paid leave.
-
The State Senate voted 21 to 15 to approve a bill that would offer such employees up to six weeks’ paid leave.
-
Mix-ups, overdoses and adverse reactions are far more common among hospitalized children than has been reported, according to a new study.
-
Scientists say they have pinpointed a genetic link that makes people more likely to become hooked on tobacco.
-
Scientists say they have pinpointed a genetic link that makes people more likely to become hooked on tobacco.
-
Scientists say they have pinpointed a genetic link that makes people more likely to become hooked on tobacco.
-
Scientists say they have pinpointed a genetic link that makes people more likely to become hooked on tobacco.
-
Chain restaurants in New York City will have until April 15 to post nutritional information for consumers.
-
The Food and Drug Administration said that recent data show patients taking H.I.V. drugs from GlaxoSmithKline and Bristol-Myers Squibb may have increased risk of heart attack.
-
The Food and Drug Administration said Thursday that it was investigating a possible link between Merck’s best-selling drug Singulair and suicide.
-
New federal guidelines recommend that manufacturers track patients receiving stents for up to five years.
-
New federal guidelines recommend that manufacturers track patients receiving stents for up to five years.
-
A federal jury convicted five former executives of a health care finance company on Thursday in a $1.9 billion scheme to defraud investors.
-
A federal jury convicted five former executives of a health care finance company on Thursday in a $1.9 billion scheme to defraud investors.
-
A federal jury convicted five former executives of a health care finance company on Thursday in a $1.9 billion scheme to defraud investors.
-
A federal jury convicted five former executives of a health care finance company on Thursday in a $1.9 billion scheme to defraud investors.
-
A federal jury convicted five former executives of a health care finance company on Thursday in a $1.9 billion scheme to defraud investors.
-
Three anemia drugs increase cancer risks to patients, federal regulators said.
-
Three anemia drugs increase cancer risks to patients, federal regulators said.
-
Three anemia drugs increase cancer risks to patients, federal regulators said.
-
After unsafe procedures spread hepatitis C at a Las Vegas clinic, inspections uncovered violations at 13 other facilities, health officials testified.
-
The subpoenas were given in a broadening investigation of a practice that was said to be unfairly costing consumers hundreds of millions of dollars.
-
The subpoenas were given in a broadening investigation of a practice that was said to be unfairly costing consumers hundreds of millions of dollars.
-
The subpoenas were given in a broadening investigation of a practice that was said to be unfairly costing consumers hundreds of millions of dollars.
-
The subpoenas were given in a broadening investigation of a practice that was said to be unfairly costing consumers hundreds of millions of dollars.
-
The subpoenas were given in a broadening investigation of a practice that was said to be unfairly costing consumers hundreds of millions of dollars.
-
The subpoenas were given in a broadening investigation of a practice that was said to be unfairly costing consumers hundreds of millions of dollars.
-
The subpoenas were given in a broadening investigation of a practice that was said to be unfairly costing consumers hundreds of millions of dollars.
-
The government hopes to start a baby boom by rewarding women who give birth to eight or more children a one-time bonus of $25 as well as free utilities.